Long-term hormone therapy may increase Alzheimer’s risk

Long term use of oral hormone therapy is associated with a slightly increased risk of Alzheimer’s disease in postmenopausal women, an observational study shows. Writing in The BMJ the authors caution that the absolute risk is small, with 9-18 additional cases per 10,000 women aged 70 to 80 per year. However they advise that physicians ...

Already a member?

Login to keep reading.

© 2021 the limbic